Pia R Mendoza1, Caroline M Craven2, Matthew H Ip3, Matthew W Wilson4, Minas T Coroneo3, Hans E Grossniklaus1,2. 1. Department of Pathology and Laboratory Medicine, Atlanta, GA, USA. 2. Department of Ophthalmology, Emory University, Atlanta, GA, USA. 3. Department of Department of Ophthalmology, University of New South Wales at Prince of Wales Hospital, Sydney, NSW, Australia. 4. Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, USA.
Abstract
AIM: To describe 4 cases of conjunctival squamous cell carcinoma (SCC) with corneal stromal invasion. METHODS: Retrospective, clinicopathologic case series. RESULTS: All patients had prior resections of presumed pterygia. The degree of corneal involvement dictated the extent of surgical management. One eye with localized invasion was treated with lamellar keratoplasty and plaque brachytherapy. Another case with widespread invasion warranted penetrating keratoplasty and eventual enucleation. Two cases were treated medically prior to surgical intervention: one with localized invasion was treated with topical interferon and retinoic acid; another with significant inflammation was treated with doxycycline and fluorometholone. The patient who underwent keratoplasty and brachytherapy had no recurrence after 7 years of follow-up. Those initially treated medically had resections of recurrence but ultimately required enucleation. Histologically, specimens demonstrated SCC invading the deep corneal stroma, with 2 tumors of the mucoepidermoid type. CONCLUSIONS: This series demonstrates the importance of maintaining clinical suspicion of conjunctival squamous neoplasia in pterygia. We recommend that all excised pterygia be submitted for histopathologic evaluation and be carefully evaluated for dysplasia and variants of SCC associated with increased risk of intraocular invasion. Undetected ocular surface squamous neoplasia may give rise to potentially vision- and eye-threatening invasive corneal SCC.
AIM: To describe 4 cases of conjunctival squamous cell carcinoma (SCC) with corneal stromal invasion. METHODS: Retrospective, clinicopathologic case series. RESULTS: All patients had prior resections of presumed pterygia. The degree of corneal involvement dictated the extent of surgical management. One eye with localized invasion was treated with lamellar keratoplasty and plaque brachytherapy. Another case with widespread invasion warranted penetrating keratoplasty and eventual enucleation. Two cases were treated medically prior to surgical intervention: one with localized invasion was treated with topical interferon and retinoic acid; another with significant inflammation was treated with doxycycline and fluorometholone. The patient who underwent keratoplasty and brachytherapy had no recurrence after 7 years of follow-up. Those initially treated medically had resections of recurrence but ultimately required enucleation. Histologically, specimens demonstrated SCC invading the deep corneal stroma, with 2 tumors of the mucoepidermoid type. CONCLUSIONS: This series demonstrates the importance of maintaining clinical suspicion of conjunctival squamous neoplasia in pterygia. We recommend that all excised pterygia be submitted for histopathologic evaluation and be carefully evaluated for dysplasia and variants of SCC associated with increased risk of intraocular invasion. Undetected ocular surface squamous neoplasia may give rise to potentially vision- and eye-threatening invasive corneal SCC.
Authors: Jerry A Shields; Ralph C Eagle; Brian P Marr; Carol L Shields; Hans E Grossniklaus; R Doyle Stulting Journal: Cornea Date: 2007-09 Impact factor: 2.651
Authors: Paul T Finger; Hoai Viet Tran; Roger E Turbin; Henry D Perry; David H Abramson; Kimberly Chin; Robert Della Rocca; Robert Ritch Journal: Arch Ophthalmol Date: 2003-02
Authors: Peter Julius; Stepfanie N Siyumbwa; Phyllis Moonga; Fred Maate; Trevor Kaile; Guobin Kang; John T West; Charles Wood; Peter C Angeletti Journal: Ocul Oncol Pathol Date: 2021-01-21
Authors: Abbas Habibalahi; Alexandra Allende; Jesse Michael; Ayad G Anwer; Jared Campbell; Saabah B Mahbub; Chandra Bala; Minas T Coroneo; Ewa M Goldys Journal: Cancers (Basel) Date: 2022-03-21 Impact factor: 6.639